Porous ureteral stent
In some embodiments, a stent includes an elongate member and a distal retention member. The elongate member is configured to be disposed within a ureter of a patient and has a first portion, a second portion and a plurality of beads bonded together. The plurality of beads define a plurality of spaces between the plurality of beads. The plurality of spaces are configured to allow fluid to flow from the first portion of the elongate member to the second portion of the elongate member. The distal retention member is configured to help maintain a portion of the stent within a kidney of the patient.
1. A stent comprising:
an elongate member having a first portion, a second portion, a plurality of beads comprising a first material and a plurality of beads comprising a second material different than the first material, each bead contacting at least one adjacent bead to define a plurality of open spaces between the plurality of beads, the plurality of open spaces configured to allow fluid to flow from the first portion of the elongate member to the second portion of the elongate member.
2. The stent of claim 1 , wherein the elongate member defines a lumen extending from the first portion of the elongate member to the second portion of the elongate member.
3. The stent of claim 1 , further comprising: a proximal retention member configured to maintain a portion of the stent within a bladder of a patient, the proximal retention member being unitarily formed.
4. The stent of claim 1 , wherein at least one bead of the plurality of beads includes a therapeutic agent.
5. The stent of claim 1 , wherein the elongate member defines a longitudinal axis and the plurality of open spaces are configured to allow fluid to flow in a direction substantially normal to the longitudinal axis.
6. The stent of claim 1 , wherein the elongate member defines a longitudinal axis and the plurality of spaces are configured to allow fluid to flow in a direction substantially normal to the longitudinal axis and in a direction substantially parallel to the longitudinal axis.
7. The stent of claim 1 , wherein the second material is dissolvable upon contact with a body fluid.
8. The stent of claim 7 , wherein the body fluid is urine.
9. The stent of claim 7 , wherein the elongate member softens as the second material dissolves.
10. The stent of claim 1 , wherein the elongate member is configured to be disposed within a ureter of a patient.
11. The stent of claim 1 , further comprising a distal retention member configured to maintain a portion of the stent within a kidney of a patient.
12. A stent comprising:
a plurality of beads comprising a first material and a plurality of beads comprising a second material different than the first material,
wherein the plurality of beads form an elongate member,
wherein each bead contacts at least one adjacent bead to define a plurality of open spaces within the elongate member, and
wherein the plurality of open spaces are configured to allow fluid to flow from a first portion of the elongate member to a second portion of the elongate member.
13. The stent of claim 12 , wherein the plurality of beads of the first and second materials define a lumen extending from the first portion of the elongate member to the second portion of the elongate member.
14. The stent of claim 12 , wherein the second material is configured to dissolve upon contact with a body fluid.
15. The stent of claim 14 , wherein the body fluid is urine.
16. The stent of claim 14 , wherein the elongate member softens as the second material dissolves.
17. The stent of claim 12 , wherein the elongate member is configured to be disposed within a ureter of a patient.
18. The stent of claim 12 , further comprising a distal retention member configured to maintain a portion of the stent within a kidney of a patient.
19. The stent of claim 12 , further comprising: a proximal retention member configured to maintain a portion of the stent within a bladder of a patient, the proximal retention member being unitarily formed.
20. The stent of claim 12 , wherein at least one bead of the plurality of beads includes a therapeutic agent.